| Haptides™ Haptides™ are new active peptides (10 - 20 amino acids
long), homologues to sequences in the
|
|
Control non-Haptide coated sepharose
beads with endothelial cells. |
Haptide coated sepharose beads
attached to endothelial cells. |
carboxy terminal chains
of fibrinogen. Some of the technological attributes of these
new peptides include: Haptide coated sepharose beads attached to endothelial
cells.
• The ability to elict attachment responses from a wide range of cell
types.
• The ability to be coupled to natural or synthetic matrices to improve
their cell binding capacity.
• Their ability to transduce drugs or biologicals into cells.
• Haptides™ are not immunogenic or toxic. |